Verition Fund Management
NVS icon

Verition Fund Management’s Novartis NVS Stock Holding History

Verition Fund Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,200
Closed -$281K – 2854
2022
Q1 		$281K Buy
+3,200
New +$277K ﹤0.01% 2186

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management's NVS Position: Q1 2026 in Review

Verition Fund Management reduced its Novartis (NVS) stake by 62% in Q1 2026, selling an estimated $712K and leaving 2,860 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Verition Fund Management first reported a position in NVS in Q3 2015 and has held it in 13 quarters since. The position peaked at $2.96M in Q2 2018. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Verition Fund Management held 2,860 shares of Novartis worth $437K as of Q1 2026.
  • Verition Fund Management sold 4,646 Novartis shares in Q1 2026, an estimated $712K.
  • Novartis made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1643 holding.
  • Verition Fund Management first reported a position in Novartis in Q3 2015 and has held it in 13 quarters since.
  • Verition Fund Management's Novartis position peaked at $2.96M in Q2 2018.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.